Effect of moderate pressure distention on the human saphenous vein vasomotor function

Annals of Thoracic Surgery

Volumn 77, Issue 1, 2004, Pages 108-114

  Okon, Elena B ^a   Millar, Michael J ^b   Crowley, Christine M ^b   Bashir, Jamil G ^b   Cook, Richard C ^b   Hsiang, York N ^b   McManus, Bruce ^b   Van Breemen, Cornelis ^b  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FASUDIL; NICARDIPINE; PHENOXYBENZAMINE; PHENYLEPHRINE; PHOSPHOTRANSFERASE INHIBITOR; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOTOR ACTIVITY; PRESSURE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; VASOMOTOR REFLEX; VASOSPASM; VEIN DILATATION; VENOCONSTRICTION;

EID: 1642523367     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.06.007     Document Type: Article

References (35)

1. Angelini G.D., Breckenridge I.M., Butchart E.G., et al. Metabolic damage to human saphenous vein during preparation for coronary artery bypass grafting. Cardiovasc Res. 19:1985;326-334.
2. Thatte HS, Khuri SF. The coronary bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg 2001;72:S2245-52.
3. Motwani J.G., Topol E.J. Autocoronary saphenous vein graft disease pathogenesis, predisposition, and prevention . Circulation. 97:1998;916-931.
4. Crowley C.M., Lee C.H., Gin S.A., Keep A.M., Cook R.C., Van Breemen C. The mechanism of excitation-contraction coupling in phenylephrine-stimulated human saphenous vein. Am J Physiol Heart Circ Physiol. 283:2002;H1271-1281.
5. Liu Z.G., Liu X.C., Yim A.P., He G.W. Direct measurement of nitric oxide release from saphenous vein abolishment by surgical preparation . Ann Thorac Surg. 71:2001;133-137.
6. Angelini G.D., Bryan A.J., Williams H.M., Morgan R., Newby A.C. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg. 99:1990;433-439.
7. Holt C.M., Francis S.E., Newby A.C., et al. Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery. Ann Thorac Surg. 55:1993;1522-1528.
8. Fitzgibbon G.M., Kafka H.P., Leach A.J., et al. Coronary bypass graft fate and patient outcome angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years . J Am Coll Cardiol. 28:1996;616-626.
9. Lytle B.W., Loop F.D., Cosgrove D.M., et al. Long-term (5 to 12 years) serial studies of internal mammary artery, and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 89:1985;248-258.
10. Wendling W.W., Krasner L.J., Cooper S.C., et al. Effects of stretch or distention on phenylephrine-induced constriction of human coronary artery bypass grafts. J Cardiothorac Vasc Anesth. 15:2001;717-722.
11. Chester A.H., Buttery L.D., Borland J.A., et al. Structural, biochemical, and functional effects of distending pressure in the human saphenous vein. implications for bypass grafting. Cor Artery Dis. 9:1998;143-151.
12. Engstrom K.G., Szentkiralyi I. Impaired contractility of left-over vein grafts used for CABG and the possible trauma caused by air exposure. Scand Cardiovasc J. 35:2001;403-408.
13. Angelini G.D., Bryan A.J., Hunter S., Newby A.C. A surgical technique that preserves human saphenous vein functional integrity. Ann Thorac Surg. 53:1992;871-874.
14. McGregor E., Gosling M., Beattie D.K., et al. Circumferential stretching of saphenous vein smooth muscle enhances vasoconstrictor response by Rho-kinase-dependent pathways. Cardiovasc Res. 53:2002;219-226.
15. Golledge J., Tumer R.J., Harley S.L., Springall D.R., Powell J.T. Development of an in vitro model to study the response of saphenous vein endothelium to pulsatile arterial flow and circumferential deformation. Eur J Vasc Endovasc Surg. 13:1997;605-612.
16. Casey P.J., Dattilo J.B., Dai G., et al. The effect of combined arterial hemodynamics on saphenous venous endothelial nitric oxide production. J Vasc Surg. 33:2001;1199-1205.
17. Bilfinger T.V., Stefano G.B. Human aortocoronary grafts and nitric oxide release relationship to pulsatile pressure . Ann Thorac Surg. 69:2000;480-485.
18. He G.-W., Rosenfeldt F.L., Angus J.A. Pharmacological relaxation of the saphenous vein during harvesting for coronary artery bypass grafting. Ann Thorac Surg. 55:1993;1210-1217.
19. Chanda J., Brichkov I., Canver C.C. Prevention of radial artery graft vasospasm after coronary bypass. Ann Thorac Surg. 70:2000;2070-2074.
20. Roubos N, Rosenfeldt FL, Richards SM, Conyers RA, Davis BB. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting. Circulation 1995;92(9 Suppl 2):II31-6.
21. Zannad F. Effect of calcium antagonists on atherosclerosis progression and intima-media thickness. Drugs. 59:2000;39-46.
22. El-Sanadiki M.N., Cross K.S., Murray J.J., et al. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Ann Surg. 212:1990;87-96.
23. Batchelor T.J., Sadaba J.R., Ishola A., et al. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol. 132:2001;301-308.
24. Rush N.J., Wooldridge T.A., Kulig C.C., et al. Reactivity of human saphenous vein at arterial perfusion pressures. J Thorac Cardiovasc Surg. 110:1995;1005-1012.
25. Bonchek L.I. Prevention of endothelial damage during preparation of saphenous veins for bypass grafting. J Thorac Cardiovasc Surg. 79:1980;911-915.
26. Qin F., Impeduglia T., Schaffer P., Dardik H. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia preliminary studies . J Vasc Surg. 37:2003;433-439.
27. Gerthoffer W.T., Gunst S.J. Invited review focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle . J Appl Physiol. 91:2001;963-972.
28. Numaguchi K., Eguchi S., Yamakawa T., Motley E.D., Inagami T. Machanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filament. Circ Res. 85:1999;5-11.
29. Sawada N., Itoh H., Ueyama K., et al. Inhibition of Rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation. 101:2000;2030-2033.
30. Shibata R., Kai H., Seki Y., et al. Role of Rho-associated kinase in neointima formation after vascular injury. Circulation. 103:2001;284-289.
31. Mack C.P., Somlyo A.V., Hautmann M., Somlyo A.P., Owens G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem. 276:2001;341-347.
32. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signalling. Hypertension 2002;39:438-2.
33. Sauzeau V., Le Jeune H., Cario-Toumaniantz C., et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem. 275:2000;21722-21729.
34. Mehta D., George S.J., Jeremy J.Y., et al. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nature Med. 4:1998;235-239.
35. Souza D.S., Dashwood M.R., Tsui J.C., et al. Improved patency in vein grafts harvested with surrounding tissue results of a randomized study using three harvesting techniques . Ann Thorac Surg. 73:2002;1189-1195.